Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. Telotristatethyl (karzinoid-syndrom-bedingte diarrhö): bewertung gemäß § 35a abs. 1 satz 11 SGB V; dossierbewertung; auftrag G17-1. [Telotristat ethyl (carcinoid syndrome diarrhoea) - benefit assessment according to §35a (1), sentence 11, Social Code Book V] Cologne: Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). IQWiG-Berichte 581. 2018 Indexing Status Subject indexing assigned by CRD MeSH Diarrhea; Humans; Malignant Carcinoid Syndrome; Phenylalanine; Pyrimidines; telotristat ethyl Country of organisation Germany English summary There is no English language summary available. Address for correspondence IQWiG, Im Mediapark 8, DE-50670 Cologne, GERMANY, Tel: +49 (0) 221 - 35685 - 0, Fax: +49 (0) 221 - 35685 - 1 Email: berichte@iqwig.de AccessionNumber 32018000057 Date abstract record published 06/02/2018 |